Health In Tech, Inc.

Q2 2026 revenue was $8.1 million, down 13.5% from $9.3 million in Q2 2025. First-half 2026 revenue was $16.8 million versus $17.3 million in the first half of 2025. Adjusted EBITDA was negative $1.3 million in Q2 and negative $2.6 million in the first half, versus positive $1.6 million and $2.8 million, respectively, in the prior-year periods. Net loss was $2.5 million, or $0.04 per diluted share, in Q2 versus net income of $0.6 million, or $0.01 per diluted share, a year ago; first-half net loss was $1.4 million, or $0.07 per diluted share, versus net income of $1.1 million, or $0.02 per diluted share. Contracted revenue for 1H26 was $32.3 million, and pipeline revenue as of July 31 was $66.3 million. The company ended the quarter with $6.5 million in cash and cash equivalents and $11.8 million in working capital. Management reaffirmed full-year 2026 revenue guidance of $45 million to $50 million, said $14 million of contracted revenue is expected in 2H26 and $1 million in 2027, and described a pipeline conversion range of 15% to 40% on the $64.4 million not yet contracted.

Tim Johnson framed Health In Tech as an early-stage platform company whose value is driven more by architecture, distribution expansion, and revenue visibility than by a single quarter’s reported revenue. He emphasized the company’s AI-enabled marketplace model, the expanding broker network of 933 distribution partners, and the strategic importance of adding carriers and launching HitRix for the large-group market. His tone was highly optimistic and explanatory, repeatedly stressing that the Q2 revenue decline was a timing issue tied to onboarding a new carrier and that the company is building for scale.

Julia Qian focused on the hard numbers and the company’s newer metrics: $32.3 million of contracted revenue in 1H26, $66.3 million of pipeline revenue as of July 31, and $84 million of platform place-to-plan value as of June 30. She reiterated that Q2 revenue of $8.1 million was down 13.5% due to timing, while first-half revenue was $16.8 million; adjusted EBITDA was negative $1.3 million in Q2 and negative $2.6 million year to date. She also noted $6.5 million of cash, $11.8 million of working capital, operating cash used of $2.9 million in Q2, and said gross margin should be around 45% to 50% going forward as the company leans into a partner-led distribution model.

Analysts focused on three main issues: the effect of the carrier change and A-rating need, the expected ramp from HitRix, and the size/timing of the 3-year stabilization program. Management said the new carrier is being switched so the company can work with larger brokers that require an A-rated carrier, and Tim Johnson suggested that getting that rating could lift projections by 20% to 30% over time, though he stressed the impact is more forward-looking than in Q2. On HitRix, management said existing brokers will get immediate access when it launches in the next 2 to 3 weeks (later described as 15 to 20 days), and on the stabilization program they said the first employer group is already signed and the pipeline may see about 30 submissions a month or more.